Cortisol; Hypersecretion
9
2
2
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (9)
SPI-62 as a Treatment for Adrenocorticotropic Hormone-dependent Cushing's Syndrome
Type 2 Diabetes, Obesity and Cortisol Excess
The Effect of Oral Whey Consumption on Insulin Resistance, Cortisol, Crp, Albumin Level and Healing Quality Before Total Hip Arthroplasty
Cellular Immunity, Neuroendocrine, and Inflammatory Factors for Clinical Prognosis in Acute Coronary Syndrome
The Efficacy of Suvorexant in Treatment of Patients With Substance Use Disorder and Insomnia: A Pilot Open Trial
Effect of Maternal Cortisol Levels on Fetal Heart Rate Patterns
Salivary Immune/Stress Biomarkers Among Children
Influence of Intrathecal Dexamethasone Administration for Proximal Femoral Fractures
Neuroactive Steroids in Acute Ischemic Stroke